Cite
HARVARD Citation
Italiano, A. et al. (n.d.). LBA67Cabozantinib in patients with advanced osteosarcomas and Ewing sarcomas: A French Sarcoma Group (FSG)/ US National Cancer Institute phase II collaborative study. Annals of oncology. p. . [Online].